Business Description
Palvella Therapeutics is a Wayne, Pennsylvania-based medical company working to bring new treatments to people living with rare and serious inherited skin conditions. Its primary focus is a topical gel called QTORIN rapamycin, which is currently being tested in late-stage clinical trials for patients with certain vascular skin disorders. The company is also exploring additional uses of this gel, along with a separate treatment called QTORIN pitavastatin, targeting other hard-to-treat skin diseases.
